Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


Articles published in J Thorac Cardiovasc Surg

Retrieve available abstracts of 180 articles:
HTML format



Single Articles


    October 2021
  1. HANNA WC
    Commentary: Wedge versus segmentectomy-It is best to err on the side of caution.
    J Thorac Cardiovasc Surg. 2021;162:1254.
    PubMed    


    September 2021
  2. DELMAN AM, Van Haren RM
    Commentary: Mitigating lung cancer mortality in patients with end-stage renal disease.
    J Thorac Cardiovasc Surg. 2021 Sep 27. pii: S0022-5223(21)01389.
    PubMed    


  3. SAITO T, Murakawa T, Shintani Y, Okami J, et al
    Preoperative renal dysfunction and long-term survival after surgery for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2021 Sep 10. pii: S0022-5223(21)01311.
    PubMed     Abstract available


  4. FARMER DM, Ripley RT
    Commentary: EGFR mutations lung adenocarcinoma-Is the driver removed with the lobe?
    J Thorac Cardiovasc Surg. 2021;162:675-676.
    PubMed    


  5. KHORFAN R, Cooke DT, Meguid RA, Backhus L, et al
    Institutional factors associated with adherence to quality measures for stage I and II non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2021;162:649-660.
    PubMed     Abstract available


  6. DENG C, Zhang Y, Ma Z, Fu F, et al
    Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma.
    J Thorac Cardiovasc Surg. 2021;162:664-674.
    PubMed     Abstract available


    August 2021
  7. EGYUD M, Burt BM
    Commentary: The structure of structural racism revealed by lung cancer screening.
    J Thorac Cardiovasc Surg. 2021 Aug 24. pii: S0022-5223(21)01248.
    PubMed    


  8. SIENICKI E, Onaitis M
    Commentary: New players in epidermal growth factor receptor tyrosine kinase inhibitor resistance.
    J Thorac Cardiovasc Surg. 2021;162:474-475.
    PubMed    


  9. FU F, Zhang Y, Wang S, Li Y, et al
    Computed tomography density is not associated with pathological tumor invasion for pure ground-glass nodules.
    J Thorac Cardiovasc Surg. 2021;162:451-459.
    PubMed     Abstract available


  10. YOSHIYASU N, Kojima F, Hayashi K, Bando T, et al
    Radiomics technology for identifying early-stage lung adenocarcinomas suitable for sublobar resection.
    J Thorac Cardiovasc Surg. 2021;162:477-485.
    PubMed     Abstract available


    July 2021
  11. CHUDGAR NP, Stiles BM
    Commentary: Adjuvant therapy in resected T1 2N0 non-small cell lung cancer: Surgeons should lead.
    J Thorac Cardiovasc Surg. 2021 Jul 14. pii: S0022-5223(21)01036.
    PubMed    


  12. WOODARD GA, Li A, Boffa DJ
    Role of adjuvant therapy in T1-2N0 resected non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2021 Jul 10. pii: S0022-5223(21)01032.
    PubMed    


  13. WANG SX, Marshall MB
    Commentary: A new hope: Do ADAURA trial results change the paradigm for treatment of resectable lung adenocarcinoma?
    J Thorac Cardiovasc Surg. 2021;162:293-294.
    PubMed    


  14. ANTONOFF MB, Morris VK
    Reply from author: Biology is king, but metastasectomy still has a role for properly selected patients.
    J Thorac Cardiovasc Surg. 2021;162:e136-e138.
    PubMed    


  15. CAMERON RB
    Reply: Discussions regarding pulmonary metastasectomy are similar to American politics: Both are extremely polarizing, unsatisfying, inconclusive, and undertaken at your own peril.
    J Thorac Cardiovasc Surg. 2021;162:e135-e136.
    PubMed    


  16. HIRPARA DH, Kidane B
    Commentary: VATS, RATS, stats, and some caveats.
    J Thorac Cardiovasc Surg. 2021;162:269-270.
    PubMed    


  17. SIHAG S
    Commentary: Sarcomas and sarcomatoid tumors of the lung...not your average lung cancers.
    J Thorac Cardiovasc Surg. 2021;162:285-286.
    PubMed    


  18. JONES DR, Wu YL, Tsuboi M, Herbst RS, et al
    Targeted therapies for resectable lung adenocarcinoma: ADAURA opens for thoracic oncologic surgeons.
    J Thorac Cardiovasc Surg. 2021;162:288-292.
    PubMed    


  19. CORSINI EM, Mitchell KG, Correa A, Morris VK, et al
    Effect of primary colorectal cancer tumor location on survival after pulmonary metastasectomy.
    J Thorac Cardiovasc Surg. 2021;162:296-305.
    PubMed     Abstract available


  20. ROBINSON LA, Babacan NA, Tanvetyanon T, Henderson-Jackson E, et al
    Results of treating primary pulmonary sarcomas and pulmonary carcinosarcomas.
    J Thorac Cardiovasc Surg. 2021;162:274-284.
    PubMed     Abstract available


  21. KAMEL MK, Lee B, Harrison SW, Port JL, et al
    Sublobar resection is comparable to lobectomy for screen-detected lung cancer.
    J Thorac Cardiovasc Surg. 2021 Jul 1. pii: S0022-5223(21)01011.
    PubMed     Abstract available


    May 2021
  22. ISBELL JM, Li BT, Gomez DR
    The emerging role of local therapy in oligometastatic non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2021 May 29. pii: S0022-5223(21)00875.
    PubMed    


  23. DONINGTON JS
    Commentary: Why do we operate in metastatic lung cancer?
    J Thorac Cardiovasc Surg. 2021 May 8. pii: S0022-5223(21)00771.
    PubMed    


  24. WIGHTMAN SC, Kim AW
    Commentary: When less is more for lung cancers.
    J Thorac Cardiovasc Surg. 2021;161:1650-1651.
    PubMed    


  25. CERFOLIO RJ
    Commentary: Let us raise the bar higher for better patient outcomes.
    J Thorac Cardiovasc Surg. 2021;161:1649-1650.
    PubMed    


  26. WEKSLER B, Sullivan JL, Schumacher LY
    Randomized trial of bupivacaine with epinephrine versus bupivacaine liposome suspension in patients undergoing minimally invasive lung resection.
    J Thorac Cardiovasc Surg. 2021;161:1652-1661.
    PubMed     Abstract available


    April 2021
  27. FERNANDEZ R, Ahmad U
    Commentary: A new hope-neoadjuvant immunotherapy for resectable non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2021 Apr 27. pii: S0022-5223(21)00740.
    PubMed    


  28. BONNER SN, Wakeam E
    The volume-outcome relationship in lung cancer surgery: The impact of the social determinants of health care delivery.
    J Thorac Cardiovasc Surg. 2021 Apr 20. pii: S0022-5223(21)00593.
    PubMed    


  29. TONG BC, Gu L, Wang X, Wigle DA, et al
    Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2021 Apr 9. pii: S0022-5223(21)00583.
    PubMed     Abstract available


  30. GROTH SS, Ripley RT
    Commentary: Cisplatin-induced nephrotoxicity following cytoreductive surgery and heated intraoperative chemotherapy for malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2021;161:1519-1520.
    PubMed    


  31. EBRIGHT MI
    Commentary: Acute kidney injury after intrapleural cisplatin: Minimizing collateral damage.
    J Thorac Cardiovasc Surg. 2021;161:1522-1523.
    PubMed    


  32. BRIBRIESCO A
    Commentary: Winning the battle for local control without losing war for survival against malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2021;161:1520-1522.
    PubMed    


  33. VARELA G
    Commentary: Extended disease, but still not the end for patients.
    J Thorac Cardiovasc Surg. 2021;161:1507-1508.
    PubMed    


  34. STILES BM
    Commentary: Think systemically, act locally.
    J Thorac Cardiovasc Surg. 2021;161:1505-1506.
    PubMed    


  35. VEERAMACHANENI NK
    Commentary: Ground-glass opacity-an unexpected silver lining.
    J Thorac Cardiovasc Surg. 2021;161:1481-1482.
    PubMed    


  36. YENDAMURI S
    Commentary: A picture really is worth a thousand words.
    J Thorac Cardiovasc Surg. 2021;161:1482-1483.
    PubMed    


  37. HOD T, Freedberg KJ, Motwani SS, Chen M, et al
    Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2021;161:1510-1518.
    PubMed     Abstract available


    March 2021
  38. ELY S, Jiang SF, Dominguez DA, Patel AR, et al
    Effect of thoracic surgery regionalization on long-term survival after lung cancer resection.
    J Thorac Cardiovasc Surg. 2021 Mar 20. pii: S0022-5223(21)00530.
    PubMed     Abstract available


  39. ANTONOFF MB, Sofocleous CT, Callstrom MR, Nguyen QN, et al
    The roles of surgery, stereotactic radiation, and ablation for treatment of pulmonary metastases.
    J Thorac Cardiovasc Surg. 2021 Mar 6. pii: S0022-5223(21)00423.
    PubMed    


  40. TONG BC
    Commentary: Safety first!
    J Thorac Cardiovasc Surg. 2021;161:803-804.
    PubMed    


  41. RAYMOND DP
    Commentary: We need more surgeons!
    J Thorac Cardiovasc Surg. 2021;161:804-805.
    PubMed    


  42. IMAI T, Weksler B
    Commentary: Eurolung score as a predictor of long-term survival: It is not all about the tumor.
    J Thorac Cardiovasc Surg. 2021;161:788-789.
    PubMed    


  43. DONAHOE LL, Nason GJ, Bedard PL, Hansen AR, et al
    Pathologic concordance of resected metastatic nonseminomatous germ cell tumors in the chest.
    J Thorac Cardiovasc Surg. 2021;161:856-868.
    PubMed     Abstract available


  44. SHEMANSKI KA, Farias A, Lieu D, Kim AW, et al
    Understanding thoracic surgeons' perceptions of administrative database analyses and guidelines in clinical decision-making.
    J Thorac Cardiovasc Surg. 2021;161:807-816.
    PubMed     Abstract available


    February 2021
  45. IMAI T, Weksler B
    Commentary: Open or VATS? Roll up your sleeve.
    J Thorac Cardiovasc Surg. 2021;161:414-415.
    PubMed    


  46. CHUDGAR NP, Bott MJ
    Commentary: Minimally invasive sleeve lobectomy: Time to roll up our "sleeves" and learn something new?
    J Thorac Cardiovasc Surg. 2021;161:415-416.
    PubMed    


  47. RIPLEY RT
    Commentary: Drawing the target after shooting the arrow: The importance of trial design.
    J Thorac Cardiovasc Surg. 2021;161:443-444.
    PubMed    


  48. GERACI TC, Ng T
    Commentary: Overreliance of propensity-score matched studies in thoracic surgery.
    J Thorac Cardiovasc Surg. 2021;161:417-418.
    PubMed    


    January 2021
  49. VEERAMACHANENI NK
    Commentary: Computed tomography screening for lung cancer at large in China: Early cure or definitive overtreatment?
    J Thorac Cardiovasc Surg. 2021 Jan 13. pii: S0022-5223(21)00047.
    PubMed    


  50. YE T, Chen H
    Commentary: The ground-glass opacity: "The savior" for lung cancer?
    J Thorac Cardiovasc Surg. 2021 Jan 8. pii: S0022-5223(21)00014.
    PubMed    


    December 2020
  51. WATANABE Y, Hattori A, Nojiri S, Matsunaga T, et al
    Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Dec 29. pii: S0022-5223(20)33443.
    PubMed     Abstract available


  52. VAN RAEMDONCK D, Decaluwe H, De Leyn P, Nackaerts K, et al
    Commentary: Do we need to search for a patient's cigarettes or just count his or her wrinkles when counseling for lung cancer resection?
    J Thorac Cardiovasc Surg. 2020 Dec 25. pii: S0022-5223(20)33404.
    PubMed    


  53. HEIDEN BT, Subramanian MP, Puri V, Kozower BD, et al
    Striking a balance: Surveillance of non-small cell lung cancer after resection.
    J Thorac Cardiovasc Surg. 2020 Dec 10. pii: S0022-5223(20)33342.
    PubMed    


  54. AL NATOUR RH, He C, Clark MJ, Welsh R, et al
    The influence of tobacco load versus smoking status on outcomes following lobectomy for lung cancer in a statewide quality collaborative.
    J Thorac Cardiovasc Surg. 2020 Dec 10. pii: S0022-5223(20)33305.
    PubMed     Abstract available


  55. ABBAS AE
    Commentary: The value of close surveillance after lung cancer surgery: How absence of evidence is not evidence of absence.
    J Thorac Cardiovasc Surg. 2020 Dec 3. pii: S0022-5223(20)33213.
    PubMed    


  56. HENNON M, Groman A, Kumar A, Castaldo L, et al
    Correlation between perioperative outcomes and long-term survival for non-small lung cancer treated at major centers.
    J Thorac Cardiovasc Surg. 2020 Dec 3. pii: S0022-5223(20)33194.
    PubMed     Abstract available


  57. LIU C, Liao H, Guo C, Pu Q, et al
    Single-direction thoracoscopic basal segmentectomy.
    J Thorac Cardiovasc Surg. 2020;160:1586-1594.
    PubMed     Abstract available


    November 2020
  58. D'AMICO TA
    Commentary: Surgery for small cell lung cancer: This is the way.
    J Thorac Cardiovasc Surg. 2020 Nov 28. pii: S0022-5223(20)33173.
    PubMed    


  59. ZHOU N, Bott M, Park BJ, Vallieres E, et al
    Predictors of survival following surgical resection of limited-stage small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Nov 27. pii: S0022-5223(20)33137.
    PubMed     Abstract available


  60. ONAITIS M
    Commentary: Survival after small cell lung cancer resection: Small opportunity?
    J Thorac Cardiovasc Surg. 2020 Nov 24. pii: S0022-5223(20)33131.
    PubMed    


  61. SWANSON SJ
    Commentary: Find, resect, and treat: The evolving early-stage small cell lung cancer story.
    J Thorac Cardiovasc Surg. 2020 Nov 21. pii: S0022-5223(20)33080.
    PubMed    


  62. SUN C, Anraku M, Kawahara T, Karasaki T, et al
    Respiratory strength and pectoralis muscle mass as measures of sarcopenia: Relation to outcomes in resected non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Nov 19. pii: S0022-5223(20)33059.
    PubMed     Abstract available


  63. SUZUKI K, Watanabe SI, Wakabayashi M, Saji H, et al
    A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer.
    J Thorac Cardiovasc Surg. 2020 Nov 12. pii: S0022-5223(20)33043.
    PubMed     Abstract available


  64. SESTI J, Paul S
    Commentary: Burn, baby, burn.
    J Thorac Cardiovasc Surg. 2020;160:1348-1349.
    PubMed    


  65. KIM SS, Bharat A
    Commentary: Video-assisted thoracoscopic surgery versus robotic assisted surgery: Are we asking the right question?
    J Thorac Cardiovasc Surg. 2020;160:1374-1375.
    PubMed    


  66. LIN J
    Commentary: The wizard of OS: Is overall survival better after sublobar resection versus stereotactic radiation or ablation?
    J Thorac Cardiovasc Surg. 2020;160:1358-1359.
    PubMed    


  67. LANUTI M
    Commentary: Can big data effectively answer important clinical questions?
    J Thorac Cardiovasc Surg. 2020;160:1361-1362.
    PubMed    


  68. SONG KJ, Flores RM
    Commentary: Robot-assisted segmentectomy is safe and expensive-What is the debate?
    J Thorac Cardiovasc Surg. 2020;160:1373-1374.
    PubMed    


  69. DENLINGER CE
    Commentary: To wedge or not to wedge.
    J Thorac Cardiovasc Surg. 2020;160:1359-1360.
    PubMed    


    October 2020
  70. TSUTANI Y, Handa Y, Shimada Y, Ito H, et al
    Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Oct 22. pii: S0022-5223(20)32833.
    PubMed     Abstract available


  71. BEAMER S, D'Cunha J
    Commentary: Using the entire toolbox for improved survival in anaplastic lymphoma kinase-positive non-small cell lung cancer: The next normal?
    J Thorac Cardiovasc Surg. 2020 Oct 17. pii: S0022-5223(20)32858.
    PubMed    


  72. MUENYI C, Ng T
    Commentary: Sublobar resection, closing in as the standard in surgical management for a subgroup of patients with lung cancer.
    J Thorac Cardiovasc Surg. 2020 Oct 17. pii: S0022-5223(20)32848.
    PubMed    


  73. MUNIAPPAN A
    Commentary: One size does not fit ALK-Targeted therapy, local ablation of recurrence, and improved outcomes after resection of ALK-positive lung cancer.
    J Thorac Cardiovasc Surg. 2020 Oct 17. pii: S0022-5223(20)32856.
    PubMed    


  74. LANUTI M
    Commentary: Comparing sleeve lobectomy with pneumonectomy for central lung cancer: A randomized study will never be conducted.
    J Thorac Cardiovasc Surg. 2020 Oct 13. pii: S0022-5223(20)32818.
    PubMed    


  75. SCARCI M, Raveglia F
    Commentary: Ground-glass opacity-dominant lung cancer. Is every R0 wedge resection always a good wedge resection?
    J Thorac Cardiovasc Surg. 2020 Oct 13. pii: S0022-5223(20)32830.
    PubMed    


  76. PASS HI
    Commentary: Tasting individual ingredients of meso soup: Can 'omics bring out the flavor?
    J Thorac Cardiovasc Surg. 2020;160:1084-1085.
    PubMed    


  77. SEVERSON DT, De Rienzo A, Bueno R
    Mesothelioma in the age of "Omics": Before and after The Cancer Genome Atlas.
    J Thorac Cardiovasc Surg. 2020;160:1078-1083.
    PubMed    


  78. RIPLEY RT
    Commentary: Filling up my truck from an oil tanker: Can big 'omic' data influence our clinical decisions?
    J Thorac Cardiovasc Surg. 2020;160:1086-1087.
    PubMed    


  79. DAVID EA, Atay SM
    Commentary: To scan or not to scan: No longer the question for mesothelioma patients after pleurectomy.
    J Thorac Cardiovasc Surg. 2020;160:1076-1077.
    PubMed    


  80. CAMERON RB
    Commentary: Mesothelioma: The Guinness world record holder in thromboembolism.
    J Thorac Cardiovasc Surg. 2020;160:1074-1075.
    PubMed    


  81. DEMMY TL
    Commentary: Positive pressure toward a negative trial?
    J Thorac Cardiovasc Surg. 2020;160:1062-1063.
    PubMed    


  82. CORSINI EM, Antonoff MB
    Commentary: Work in progress-Defining optimal surgical prehabilitation before lung resection.
    J Thorac Cardiovasc Surg. 2020;160:1060-1061.
    PubMed    


  83. DE LEON LE, Bravo-Iniguez CE, Fox S, Tarascio J, et al
    Routine surveillance for diagnosis of venous thromboembolism after pleurectomy for malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2020;160:1064-1073.
    PubMed     Abstract available


    September 2020
  84. HO H, Williamson C, Regis SM, Stock CT, et al
    Surgery and invasive diagnostic procedures for benign disease are rare in a large low-dose computed tomography lung cancer screening program.
    J Thorac Cardiovasc Surg. 2020 Sep 8. pii: S0022-5223(20)32573.
    PubMed     Abstract available


  85. RAKOVICH G, Bujold A
    The "multispecialty clinic": Toward a new paradigm in thoracic oncology?
    J Thorac Cardiovasc Surg. 2020;160:e176-e177.
    PubMed    


  86. MORI M, Geirsson A
    Reply from authors: Identifying lessons that could be generalized across different disease burdens.
    J Thorac Cardiovasc Surg. 2020;160:e133-e134.
    PubMed    


  87. SONG KJ, Flores RM
    REPLY: ROBOTIC-ASSISTED SEGMENTECTOMY: DOING IT SIMPLY BECAUSE WE CAN?
    J Thorac Cardiovasc Surg. 2020;160:e176.
    PubMed    


  88. MADARIAGA ML, Gaissert HA
    Reply from authors: The many benefits of a multidisciplinary evaluation of lung nodules.
    J Thorac Cardiovasc Surg. 2020;160:e177-e178.
    PubMed    


  89. ZHANG Y, Chen X, Li H
    Robotic or thoracoscopic segmentectomy: Each complements the other.
    J Thorac Cardiovasc Surg. 2020;160:e175.
    PubMed    


  90. VEERAMACHANENI NK
    Commentary: Minimally invasive sleeve lobectomy-from case report curiosity to standard of care?
    J Thorac Cardiovasc Surg. 2020;160:852-853.
    PubMed    


  91. CERFOLIO RJ
    Commentary: Why so many sleeve resections and pneumonectomies and why the nonabsorbable suture?
    J Thorac Cardiovasc Surg. 2020;160:847-848.
    PubMed    


  92. LAZZARO R, Patton B
    Commentary: Maximum surgery through minimal incisions.
    J Thorac Cardiovasc Surg. 2020;160:849-850.
    PubMed    


  93. MATTHEWS CR, Hess PJ
    Thirty-three, zero, nine.
    J Thorac Cardiovasc Surg. 2020;160:871-875.
    PubMed    


  94. CHU NQ, Liu R, Colby A, de Forcrand C, et al
    Paclitaxel-loaded expansile nanoparticles improve survival following cytoreductive surgery in pleural mesothelioma xenografts.
    J Thorac Cardiovasc Surg. 2020;160:e159-e168.
    PubMed     Abstract available


  95. ZHANG Y, Jheon S, Li H, Zhang H, et al
    Results of low-dose computed tomography as a regular health examination among Chinese hospital employees.
    J Thorac Cardiovasc Surg. 2020;160:824-831.
    PubMed     Abstract available


    August 2020
  96. STILES BM
    Commentary: Overcoming the dangerous narrative of computed tomography screening for lung cancer.
    J Thorac Cardiovasc Surg. 2020 Aug 28. pii: S0022-5223(20)32464.
    PubMed    


  97. BRUNELLI A, Chaudhuri N, Kefaloyannis M, Milton R, et al
    Eurolung risk score is associated with long-term survival after curative resection for lung cancer.
    J Thorac Cardiovasc Surg. 2020 Aug 24. pii: S0022-5223(20)32431.
    PubMed     Abstract available


  98. CHEN KN
    Commentary: Not only safety but also efficacy is required in repeat pulmonary resection for second non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Aug 8. pii: S0022-5223(20)32360.
    PubMed    


  99. LIU C, Tian D, Pu Q
    Do not go too far when choosing intentional segmentectomy for small-sized lung cancers.
    J Thorac Cardiovasc Surg. 2020;160:e85-e86.
    PubMed    


  100. RAZI SS, Nguyen D, Villamizar N
    Reply from authors: Positive nodes after segmentectomy: Take a deep breath and give adjuvant treatment.
    J Thorac Cardiovasc Surg. 2020;160:e86-e87.
    PubMed    


  101. JEFFREY YANG CF, Berry MF
    Reply: The importance of appropriate selection for segmentectomy.
    J Thorac Cardiovasc Surg. 2020;160:e87.
    PubMed    


  102. LAZAR JF
    Commentary: How to "spot" a leopard: It's in the genes.
    J Thorac Cardiovasc Surg. 2020;160:e82-e83.
    PubMed    


  103. PATEL S, Kim AW
    Commentary: Standing on similar, but different, shoulders.
    J Thorac Cardiovasc Surg. 2020;160:e81-e82.
    PubMed    


  104. PENG S, Huang L, Zhao B, Zhou S, et al
    Clinical course of coronavirus disease 2019 in 11 patients after thoracic surgery and challenges in diagnosis.
    J Thorac Cardiovasc Surg. 2020;160:585-592.
    PubMed     Abstract available


  105. HUANG J, Wang A, Kang G, Li D, et al
    Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery.
    J Thorac Cardiovasc Surg. 2020;160:e91-e93.
    PubMed    


  106. FAN L, Yang H, Yu L, Wang Z, et al
    Multicenter, prospective, observational study of a novel technique for preoperative pulmonary nodule localization.
    J Thorac Cardiovasc Surg. 2020;160:532-539.
    PubMed     Abstract available


    July 2020
  107. D'ANDRILLI A, Rendina EA
    Commentary: Second ipsilateral metachronous lung cancer: What to do?
    J Thorac Cardiovasc Surg. 2020 Jul 24. pii: S0022-5223(20)32224.
    PubMed    


  108. HATTORI A, Matsunaga T, Watanabe Y, Fukui M, et al
    Repeated anatomical pulmonary resection for metachronous ipsilateral second non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 16. pii: S0022-5223(20)32150.
    PubMed     Abstract available


  109. ZAMBETTI BR, Ng T
    Commentary: Patient frailty also drives long-term outcomes after R0 resection for lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 14. pii: S0022-5223(20)32079.
    PubMed    


  110. SUDARSHAN M, Murthy SC
    Commentary: Using nutritional scoring systems to predict outcomes after lung cancer surgery: Food for thought.
    J Thorac Cardiovasc Surg. 2020 Jul 13. pii: S0022-5223(20)32051.
    PubMed    


  111. BAZHENOVA L, Urbanic J, Onaitis M
    Commentary: Epidermal growth factor receptor mutations in resectable lung cancer: What is the prognostic importance?
    J Thorac Cardiovasc Surg. 2020 Jul 13. pii: S0022-5223(20)32054.
    PubMed    


  112. WALLACE AF, Weksler B
    Commentary: Food for thought: Assessing the influence of malnutrition in patients with lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 10. pii: S0022-5223(20)32042.
    PubMed    


  113. NELSON DB, Antonoff MB
    Commentary: The prognostic value of Kirsten rat sarcoma viral oncogene mutation for non-small cell lung cancer: One size does not always fit all.
    J Thorac Cardiovasc Surg. 2020 Jul 5. pii: S0022-5223(20)31990.
    PubMed    


  114. STILES BM, Sepesi B, Broderick SR, Bott MJ, et al
    Perioperative considerations for neoadjuvant immunotherapy in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 5. pii: S0022-5223(20)31987.
    PubMed    


  115. SALAZAR MC, Boffa DJ
    Commentary: The majority of minorities.
    J Thorac Cardiovasc Surg. 2020;160:272-273.
    PubMed    


  116. HAMMOUD ZT
    Commentary: Despair and disparity.
    J Thorac Cardiovasc Surg. 2020;160:275.
    PubMed    


  117. CORNWELL LD, Ripley RT
    Commentary: Beyond the eyeball test.
    J Thorac Cardiovasc Surg. 2020;160:285-286.
    PubMed    


  118. JONES GD, Tan KS, Caso R, Dycoco J, et al
    Time-varying analysis of readmission and mortality during the first year after pneumonectomy.
    J Thorac Cardiovasc Surg. 2020;160:247-255.
    PubMed     Abstract available


    June 2020
  119. TAKAHASHI M, Sowa T, Tokumasu H, Gomyoda T, et al
    Comparison of three nutritional scoring systems for outcomes after complete resection of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jun 29. pii: S0022-5223(20)31751.
    PubMed     Abstract available


  120. MUNIAPPAN A
    Commentary: Through the looking glass-radiomics and evaluation of early lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jun 26. pii: S0022-5223(20)31771.
    PubMed    


  121. LIN J
    Commentary: Mind the gap: Adherence to quality measures for stage I/II non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jun 26. pii: S0022-5223(20)31753.
    PubMed    


  122. TANG A, Ahmad U, Toth AJ, Bourdakos N, et al
    Non-small cell lung cancer in never- and ever-smokers: Is it the same disease?
    J Thorac Cardiovasc Surg. 2020 Jun 18. pii: S0022-5223(20)31395.
    PubMed     Abstract available


  123. GILES AE, Kidane B
    Commentary: Know your enemy-Understanding futility in the battle against malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2020;159:2523-2524.
    PubMed    


  124. HOANG CD
    Commentary: Surgeon versus mesothelioma in a thoracic cage match.
    J Thorac Cardiovasc Surg. 2020;159:2522-2523.
    PubMed    


  125. ANDRADE R
    Commentary: Why do uniportal video-assisted thoracoscopic lobectomy?
    J Thorac Cardiovasc Surg. 2020;159:2496-2497.
    PubMed    


  126. BOFFA DJ, Salazar M
    Commentary: How surprising.
    J Thorac Cardiovasc Surg. 2020;159:2483-2484.
    PubMed    


  127. DE PERROT M
    Commentary: Is thoracic cage volume a new parameter for clinical staging in mesothelioma?
    J Thorac Cardiovasc Surg. 2020;159:2520-2521.
    PubMed    


  128. BURT BM, Lee HS, Raghuram AC, Strange C, et al
    Preoperative prediction of unresectability in malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2020;159:2512-2520.
    PubMed     Abstract available


  129. HYLTON DA, Turner S, Kidane B, Spicer J, et al
    The Canada Lymph Node Score for prediction of malignancy in mediastinal lymph nodes during endobronchial ultrasound.
    J Thorac Cardiovasc Surg. 2020;159:2499-2507.
    PubMed     Abstract available


  130. VIEIRA A, Bourdages-Pageau E, Kennedy K, Ugalde PA, et al
    The learning curve on uniportal video-assisted thoracic surgery: An analysis of proficiency.
    J Thorac Cardiovasc Surg. 2020;159:2487-2495.
    PubMed     Abstract available


    May 2020
  131. DONINGTON JS, Paulus R, Edelman MJ, Krasna MJ, et al
    Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 May 31. pii: S0022-5223(20)31276.
    PubMed     Abstract available


  132. SESTI J, Paul S
    Commentary: More science, less fortunetelling: Using radiomics to predict the invasiveness of lung cancer.
    J Thorac Cardiovasc Surg. 2020 May 25. pii: S0022-5223(20)31268.
    PubMed    


  133. DIMOU A, Nasarre C, Peterson YK, Pagano R, et al
    Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 May 25. pii: S0022-5223(20)31233.
    PubMed     Abstract available


  134. RAJARAM R, Rice DC, Li Y, Bruera E, et al
    Postoperative opioid use after lobectomy for primary lung cancer: A propensity-matched analysis of premier hospital data.
    J Thorac Cardiovasc Surg. 2020 May 16. pii: S0022-5223(20)31136.
    PubMed     Abstract available


  135. PASS HI
    Commentary: Not only SMART clinically, but translationally!
    J Thorac Cardiovasc Surg. 2020;159:2094-2095.
    PubMed    


  136. BRUNELLI A
    Commentary: The power of indeterminacy.
    J Thorac Cardiovasc Surg. 2020;159:2041.
    PubMed    


  137. SESTI J, Paul S
    Commentary: Known unknowns and unknown unknowns: The case of the indeterminate margin.
    J Thorac Cardiovasc Surg. 2020;159:2042.
    PubMed    


  138. CHEN-YOSHIKAWA TF
    Commentary: A journey of a thousand miles begins with a single step.
    J Thorac Cardiovasc Surg. 2020;159:2092-2093.
    PubMed    


  139. SRINATHAN S
    Is ventilatory efficiency the next new thing in prehabilitation?
    J Thorac Cardiovasc Surg. 2020;159:e323-e324.
    PubMed    


  140. WAKEAM E, Adibfar A, Stokes S, Leighl NB, et al
    Defining the role of adjuvant therapy for early-stage large cell neuroendocrine carcinoma.
    J Thorac Cardiovasc Surg. 2020;159:2043-2054.
    PubMed     Abstract available


  141. MOLINA JC, Chaudry F, Menezes V, Ferraro P, et al
    Transvascular endosonographic-guided needle biopsy of intrathoracic lesions.
    J Thorac Cardiovasc Surg. 2020;159:2057-2065.
    PubMed     Abstract available


    April 2020
  142. DONINGTON J
    Commentary: Why does neoadjuvant therapy suddenly make sense for early stage non-small cell lung cancer?
    J Thorac Cardiovasc Surg. 2020 Apr 25. pii: S0022-5223(20)30999.
    PubMed    


  143. DENLINGER CE
    Commentary: Durable activity of a tyrosine kinase inhibitor in lung cancer.
    J Thorac Cardiovasc Surg. 2020 Apr 23. pii: S0022-5223(20)30985.
    PubMed    


  144. AZZOLI CG, Ng T
    Commentary: Preoperative gefitinib for stage II-III non-small cell lung cancer with EGFR mutation: A stich in time, or delay from stiches?
    J Thorac Cardiovasc Surg. 2020 Apr 18. pii: S0022-5223(20)30967.
    PubMed    


  145. HOANG CD
    Commentary: Smoke or fire? Resected lung cancer in never-smokers.
    J Thorac Cardiovasc Surg. 2020 Apr 10. pii: S0022-5223(20)30795.
    PubMed    


  146. LIM K, Hsin MKY
    Commentary: Resection for small cell lung cancer should be offered more often, and preferably anatomical.
    J Thorac Cardiovasc Surg. 2020 Apr 6. pii: S0022-5223(20)30780.
    PubMed    


  147. JEFFREY YANG CF
    Commentary: Is surgery better than chemoradiation for T3N1M0 non-small cell lung cancer?
    J Thorac Cardiovasc Surg. 2020 Apr 6. pii: S0022-5223(20)30805.
    PubMed    


  148. HATTORI A, Suzuki K, Takamochi K, Wakabayashi M, et al
    Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Apr 6. pii: S0022-5223(20)30734.
    PubMed     Abstract available


  149. LANUTI M
    Commentary: Wedge resection for limited-stage small cell lung cancer: Not an acceptable modality for curative intent.
    J Thorac Cardiovasc Surg. 2020 Apr 5. pii: S0022-5223(20)30811.
    PubMed    


  150. PASS HI
    Commentary: "Hot" gene signatures for checkpoint response prediction: A very cool idea.
    J Thorac Cardiovasc Surg. 2020;159:1611-1612.
    PubMed    


  151. WAKEAM E, Kidane B
    Commentary: Picking the winners-Leaning into selection bias.
    J Thorac Cardiovasc Surg. 2020;159:1594-1595.
    PubMed    


  152. BLESSING WA, Colson YL
    Commentary: The checkpoint before checkpoint inhibitors.
    J Thorac Cardiovasc Surg. 2020;159:1614-1615.
    PubMed    


  153. PATEL S, Kim AW
    Commentary: TiME may actually tell good from bad.
    J Thorac Cardiovasc Surg. 2020;159:1613-1614.
    PubMed    


  154. PASS HI
    Discussion.
    J Thorac Cardiovasc Surg. 2020;159:1609-1610.
    PubMed    


  155. WOLF AS
    Discussion.
    J Thorac Cardiovasc Surg. 2020;159:1556.
    PubMed    


  156. SUBRAMANIAN MP
    Commentary: Much to do about nodules-Improving care with a multidisciplinary pulmonary nodule clinic.
    J Thorac Cardiovasc Surg. 2020;159:1569-1570.
    PubMed    


  157. PARK CH, Lee SM, Lee JW, Hwang SH, et al
    Hook-wire localization versus lipiodol localization for patients with pulmonary lesions having ground-glass opacity.
    J Thorac Cardiovasc Surg. 2020;159:1571-1579.
    PubMed     Abstract available


  158. NGUYEN DM, Villamizar N
    Commentary: Preoperative localization of "hard-to-find" pulmonary ground-glass opacity: There are more than one way to find the target.
    J Thorac Cardiovasc Surg. 2020;159:1581-1583.
    PubMed    


  159. MADARIAGA ML, Lennes IT, Best T, Shepard JO, et al
    Multidisciplinary selection of pulmonary nodules for surgical resection: Diagnostic results and long-term outcomes.
    J Thorac Cardiovasc Surg. 2020;159:1558-1566.
    PubMed     Abstract available


  160. FELMLY LM, Gibney BC
    Commentary: Biphasic malignant mesothelioma-Survival of the fittest.
    J Thorac Cardiovasc Surg. 2020;159:1596-1597.
    PubMed    


  161. SESTI J, Paul S
    Commentary: GGOogle maps for the adult lung.
    J Thorac Cardiovasc Surg. 2020;159:1580.
    PubMed    


  162. LOCOCO F, Torricelli F, Lang-Lazdunski L, Veronesi G, et al
    Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
    J Thorac Cardiovasc Surg. 2020;159:1584-1593.
    PubMed     Abstract available


    March 2020
  163. OPITZ I
    Commentary: Surgery expanding to stage IV non-small cell lung cancer treatment?!
    J Thorac Cardiovasc Surg. 2020 Mar 31. pii: S0022-5223(20)30731.
    PubMed    


  164. MITCHELL KG, Farooqi A, Ludmir EB, Corsini EM, et al
    Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 25. pii: S0022-5223(20)30633.
    PubMed     Abstract available


  165. XIE D, Deng J, Gonzalez-Rivas D, Zhu Y, et al
    Comparison of video-assisted thoracoscopic surgery with thoracotomy in bronchial sleeve lobectomy for centrally located non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 25. pii: S0022-5223(20)30719.
    PubMed     Abstract available


  166. CHAN EG, Chan PG, Mazur SN, Normolle DP, et al
    Outcomes with segmentectomy versus lobectomy in patients with clinical T1cN0M0 non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 23. pii: S0022-5223(20)30706.
    PubMed     Abstract available


  167. PATNAIK SK, Cortes EG, Kannisto ED, Punnanitinont A, et al
    Lower airway bacterial microbiome may influence recurrence after resection of early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 23. pii: S0022-5223(20)30631.
    PubMed     Abstract available


  168. RAMAN V, Jawitz OK, Yang CJ, Voigt SL, et al
    The effect of extent of resection on outcomes in patients with limited stage small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 22. pii: S0022-5223(20)30634.
    PubMed     Abstract available


  169. CHOI JJ, Huang J
    Commentary: How much is enough? The extent of resection in small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 19. pii: S0022-5223(20)30588.
    PubMed    


  170. PASS HI
    Commentary: Lung cancer and dysbiosis: Debugging the studies for the future.
    J Thorac Cardiovasc Surg. 2020 Mar 19. pii: S0022-5223(20)30619.
    PubMed    


  171. ZHANG Y, Fu F, Hu H, Wang S, et al
    Gefitinib as neoadjuvant therapy for resectable stage II-IIIA non-small cell lung cancer: A phase II study.
    J Thorac Cardiovasc Surg. 2020 Mar 19. pii: S0022-5223(20)30625.
    PubMed     Abstract available


    February 2020
  172. HONG TH, Kim J, Shin S, Kim HK, et al
    Clinical outcomes of microscopic residual disease after bronchial sleeve resection for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Feb 29. pii: S0022-5223(20)30518.
    PubMed     Abstract available


  173. RAHOUMA M, Kamel M, Nasar A, Harrison S, et al
    Treatment of cT3N1M0/IIIA non-small cell lung cancer and the risk of underuse of surgery.
    J Thorac Cardiovasc Surg. 2020 Feb 24. pii: S0022-5223(20)30503.
    PubMed     Abstract available


  174. JAKLITSCH MT, Jacobson FL
    The future of lung cancer screening with low-dose computed tomography.
    J Thorac Cardiovasc Surg. 2020 Feb 19. pii: S0022-5223(20)30199.
    PubMed    


  175. NGUYEN DM, Villamizar N
    Commentary: Lower airway microbiome and non-small cell lung cancer: The beginning of a bug story.
    J Thorac Cardiovasc Surg. 2020 Feb 14. pii: S0022-5223(20)30382.
    PubMed    


  176. NELSON DB, Niu J, Mitchell KG, Antonoff MB, et al
    Perioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020;159:691-702.
    PubMed     Abstract available


  177. BOTT MJ
    Commentary: Opioid dependence in the lobectomy patient: A hard pill to swallow.
    J Thorac Cardiovasc Surg. 2020;159:703-704.
    PubMed    


  178. BACIEWICZ FA JR
    Preoperative pulmonary rehabilitation.
    J Thorac Cardiovasc Surg. 2020;159:e147-e148.
    PubMed    


  179. LINDEN PA, Perry Y, Worrell S, Wallace A, et al
    Postoperative day 1 discharge after anatomic lung resection: A Society of Thoracic Surgeons database analysis.
    J Thorac Cardiovasc Surg. 2020;159:667-678.
    PubMed     Abstract available


    September 2019
  180. CAO C, Louie BE, Melfi F, Veronesi G, et al
    Outcomes of major complications after robotic anatomic pulmonary resection.
    J Thorac Cardiovasc Surg. 2019 Sep 18. pii: S0022-5223(19)31809.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: